You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant Chemotherapy, Muscle Invasive Bladder Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)

Recruiting
  • Urinary Bladder Cancer
  • Carboplatin-Gemcitabine Cisplatin-Gemcitabine
  • Assiut, Egypt
    AssiutU
Apr 22, 2023

Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • cisplatin based neoadjuvant chemotherapy
  • Radical cystectomy alone
  • Rome, Italy
    Riccardo Mastroianni
Mar 8, 2023

Bladder Cancer Trial in Houston (Celecoxib, Gemcitabine, Cisplatin)

Recruiting
  • Bladder Cancer
  • Houston, Texas
  • +1 more
Jul 22, 2022

Upper Tract Urinary Carcinoma, Muscle-invasive Bladder Cancer Trial in Beijing (Toripalimab)

Recruiting
  • Upper Tract Urinary Carcinoma
  • Muscle-invasive Bladder Cancer
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Mar 12, 2022

Urothelial Carcinoma Trial in Milan (Sacituzumab govitecan)

Recruiting
  • Urothelial Carcinoma
  • Sacituzumab govitecan
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 7, 2022

Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

Recruiting
  • Stage II Bladder Cancer AJCC v8
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

Recruiting
  • Bladder Carcinoma
  • +7 more
  • Atezolizumab
  • +5 more
  • Toronto, Ontario, Canada
    University Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022

Bladder Cancer Trial in Aarhus (15O-H2O PET/MR)

Recruiting
  • Bladder Cancer
  • 15O-H2O PET/MR
  • Aarhus, Denmark
    Department of Urology, Aarhus University Hopsital
Jul 27, 2021

Muscle Invasive Bladder Cancer, Urothelial Carcinoma, Neoadjuvant Chemo Trial in Yangsan (dose dense MVAC with pegylated GCSF)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +2 more
  • dose dense MVAC with pegylated GCSF
  • Yangsan, Gyeongsangnam-do, Korea, Republic of
    Pusan National University Yangsan Hospital
Feb 2, 2022

Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Bladder Cancer, Adult Solid Tumor Trial in Milano, Roma, Torino (Nivolumab, Visugromab (CTL-002), Placebo)

Recruiting
  • Bladder Cancer
  • Adult Solid Tumor
  • Milano, Italy
  • +3 more
Sep 21, 2023

Muscle Invasive Bladder Cancer Trial in Boston (Durvalumab, Oleclumab)

Completed
  • Muscle Invasive Bladder Cancer
  • Boston, Massachusetts
  • +1 more
Sep 8, 2022

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Best Practice
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 18, 2023

Bladder Cancer Trial in United States (Nivolumab, Ipilimumab, Radical cystectomy)

Recruiting
  • Bladder Cancer
  • Basking Ridge, New Jersey
  • +6 more
Feb 1, 2022

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)

Completed
  • Bladder Cancer
  • intravesical mitomycin-C 40mg/20ml instillation
  • Goyang, Korea, Republic of
    National Cancer Center
Jan 30, 2023

Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

Completed
Has Results
  • Bladder Cancer
  • Tampa, Florida
  • +7 more
Nov 4, 2022

Muscle-Invasive Bladder Carcinoma Trial in Milan (Nivolumab + Nab-paclitaxel, Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Milan, MI, Italy
    Genitourinary Medical Oncology - IRCCS San Raffaele Hospital and
Mar 28, 2022

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Muscle-Invasive Bladder Carcinoma Trial in Philadelphia (AMVAC + Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • AMVAC + Nivolumab
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Apr 1, 2022

Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Jan 17, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Lymphadenectomy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023